We propose this increased caspase expression is used to support tumor stress adaptation, through enhanced PARP1 activity, autophagy, and DDR signaling, and may be a targetable vulnerability, particularly in the context of BRCA1 or other potential synthetic lethal mutations identified here. This evidence concerns the gene PARP1 and neoplasm.